SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly
LLY 1,044+0.2%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Moonray6/23/2020 10:35:03 PM
   of 642
 
Lilly's Covid-19 drug could be ready
for use as soon as Sept, says chief scientist
By Michael Erman, Carl O'Donnell , Reuters - 23 Jun 2020

Lilly is also doing preclinical studies of a third antibody
treatment for the illness caused by the new coronavirus that
could enter human clinical trials in the coming weeks, chief
scientist Daniel Skovronsky said

Eli Lilly and Co could have a drug specifically designed to
treat COVID-19 authorized for use as early as September
if all goes well with either of two antibody therapies it
is testing, its chief scientist told Reuters on Wednesday.

Lilly is also doing preclinical studies of a third antibody
treatment for the illness caused by the new coronavirus
that could enter human clinical trials in the coming weeks,
Chief Scientific Officer Daniel Skovronsky said in an interview.

Lilly has already launched human trials with two of the
experimental therapies.

More at: livemint.com

o~~~ O
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext